SANDOZ LISDEXAMFETAMINE CAPSULES

Identification of Sandoz Lisdexamfetamine Capsules

No description

Google image searchProduct monograph

Active ingredient

lisdexamfetamine dimesylate, 30 MG

DIN: 02546264

Dosage form(s): CAPSULE

Route(s) of administration: ORAL

Schedule: Schedule G (CDSA I)

Company: SANDOZ CANADA INCORPORATED

Date: 23-SEP-2024

ATC:

• N06 — PSYCHOANALEPTICS (ATC, ATC/DDD, )
• N06B — PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS (ATC, ATC/DDD)
• N06BA — Centrally acting sympathomimetics (ATC, ATC/DDD)
• N06BA12 — LISDEXAMFETAMINE (ATC/DDD)

Reference brand drug: Vyvanse

External Links for Sandoz Lisdexamfetamine Capsules

Search on Google

• Sandoz Lisdexamfetamine Capsules side effects
• Sandoz Lisdexamfetamine Capsules dosage
• lisdexamfetamine dimesylate side effects
• lisdexamfetamine dimesylate dosage

Sandoz Canada Incorporated

Go to Sandoz website to see drug product details. Sometimes you can find sandoz lisdexamfetamine capsules photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.